Clinical Trial Update: VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update (VITAL-IMPACT) sponsored by University of Alabama at Birmingham, evaluating therapeutic augmentation of the cGMP signaling pathway…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Insulin Resistance
• Obesity

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Cardiovascular Diseases, Insulin Sensitivity/Resistance | Phase 2 | Status: NOT_YET_RECRUITING